Lilly Up Around 7% in a Week: Should You Buy, Sell or Hold the Stock?
Eli Lilly and Company’s LLY stock has risen around 6.7% in a week, backed by strong company-specific news and the overall recent rally in the U.S. drug and biotech sector. Eli Lilly stock hit a new 52-week high on June 26. Last week, the European Medicines Agency's Committee for Medicinal Products…